. Author manuscript; available in PMC: 2011 Jun 21.

Published in final edited form as: J Infect Dis. 2004 Jun 30;190(3):619–623. doi: 10.1086/422533

Table 2.

Factors associated with detection of cytomegalovirus (CMV) DNA in cervicovaginal lavage (CVL) specimens from 33 HIV-1–infected women.

	Detection of CMV DNA

				Unadjusted		Adjusted^c

Variable	Positive^a	Negative^a	P^b	OR (95% CI)	P	OR (95% CI)	P
HIV RNA level, copies/mL	4487	63	.005
Detectable	9 (75.00)	8 (38.10)	.041	4.88 (1.01–23.57)	.049	6.24 (1.02–38.12)	.048
Undetectable	3 (25.00)	13 (61.90)		1.00		1.00
Receiving antiretroviral therapy^d
Yes	6 (54.55)	14 (66.67)	.501	0.6 (0.14–2.67)	.503	0.43 (0.08–2.25)	.319
No	5 (45.45)	7 (33.33)		1.00		1.00
CD4⁺ cell count, cells/mm³
<200	3 (25.00)	3 (14.29)	.520	1.25 (0.16–9.92)
200–499	5 (41.67)	13 (61.90)		0.48 (0.09–2.56)	.833
≥500	4 (33.33)	5 (23.81)		1.00	.390

NOTE.

CI, confidence interval; OR, odds ratio.

Data are no. (%) of patients (n = 33) for the categorical variables. Median values are given for the continuous variable HIV RNA level.

Determined by the Kruskal-Wallis test, for the continuous variable, or by the χ² or Fisher’s exact test, for the categorical variables.

The model was adjusted for CD4⁺ cell count (<200, 200–499, and ≥500 cells/mm³).

Because of missing data, the no. of patients in each category does not sum to the total sample size.